{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T16:35:46Z","timestamp":1780850146305,"version":"3.54.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":678,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"crossref","award":["2008-4263"],"award-info":[{"award-number":["2008-4263"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.bbmt.2013.03.003","type":"journal-article","created":{"date-parts":[[2013,3,13]],"date-time":"2013-03-13T19:45:42Z","timestamp":1363203942000},"page":"867-875","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Donor T Cells Administered Over HLA Class II Barriers Mediate Antitumor Immunity without Broad Off-Target Toxicity in a NOD\/Scid Mouse Model of Acute Leukemia"],"prefix":"10.1016","volume":"19","author":[{"given":"Sanja","family":"Stevanovi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart A.","family":"Nijmeijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianke L.J.","family":"van Schie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela C.F.","family":"Salvatori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Maas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke","family":"Griffioen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.H. Frederik","family":"Falkenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2013.03.003_bib1","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1146\/annurev.med.54.101601.152456","article-title":"The current status of hematopoietic cell transplantation","volume":"54","author":"Appelbaum","year":"2003","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.bbmt.2013.03.003_bib2","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1182\/blood.V78.8.2120.2120","article-title":"T-cell depletion of HLA-identical transplants in leukemia","volume":"78","author":"Marmont","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.03.003_bib3","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0301-472X(03)00200-5","article-title":"Minimal GVHD following in\u00a0vitro T cell-depleted allogeneic stem cell transplantation with reduced-intensity conditioning allowing subsequent infusions of donor lymphocytes in patients with hematological malignancies and solid tumors","volume":"31","author":"Barge","year":"2003","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bbmt.2013.03.003_bib4","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/sj.bmt.1701131","article-title":"T\u00a0cell depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect","volume":"21","author":"Barrett","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.03.003_bib5","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1182\/blood-2008-03-077974","article-title":"Graft-versus-leukemia effects of transplantation and donor lymphocytes","volume":"112","author":"Kolb","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.03.003_bib6","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ctrv.2010.03.004","article-title":"Role of donor lymphocyte infusions in relapsed hematological malignancies after stem cell transplantation revisited","volume":"36","author":"Deol","year":"2010","journal-title":"Cancer Treat Rev"},{"issue":"suppl 4","key":"10.1016\/j.bbmt.2013.03.003_bib7","first-page":"S34","article-title":"Immunogenetic marrow donor search for 1012 patients: a retrospective analysis of strategies, outcome and costs","volume":"14","author":"Ottinger","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.03.003_bib8","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.coi.2008.06.014","article-title":"Optimal HLA matching in hematopoietic cell transplantation","volume":"20","author":"Petersdorf","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.bbmt.2013.03.003_bib9","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev.iy.11.040193.002125","article-title":"The molecular basis of allorecognition","volume":"11","author":"Sherman","year":"1993","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.bbmt.2013.03.003_bib10","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.molimm.2006.05.018","article-title":"T\u00a0cell allorecognition and MHC restriction: a case of Jekyll and Hyde?","volume":"45","author":"Archbold","year":"2008","journal-title":"Mol Immunol"},{"key":"10.1016\/j.bbmt.2013.03.003_bib11","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1182\/blood.V63.5.1125.1125","article-title":"Polymorphic and monomorphic HLA-DR determinants on human hematopoietic progenitor cells","volume":"63","author":"Falkenburg","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.03.003_bib12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0198-8859(84)90029-6","article-title":"Expression of HLA-DR alloantigens on acute lymphoblastic leukemia lymphoblasts","volume":"9","author":"Orgad","year":"1984","journal-title":"Hum Immunol"},{"issue":"4 Pt 1","key":"10.1016\/j.bbmt.2013.03.003_bib13","first-page":"1783","article-title":"Expression of HLA class II (DR, DQ) determinants by normal and chronic myeloid leukemia granulocyte\/monocyte progenitors","volume":"46","author":"Aglietta","year":"1986","journal-title":"Cancer Res"},{"key":"10.1016\/j.bbmt.2013.03.003_bib14","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/sj.bmt.1701768","article-title":"Recognition of leukemic blasts by HLA-DPB1\u2013specific cytotoxic T cell clones: a perspective for adjuvant immunotherapy post-bone marrow transplantation","volume":"23","author":"Ibisch","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.03.003_bib15","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/leu.2008.90","article-title":"HLA-DP as specific target for cellular immunotherapy in HLA class II\u2013expressing B-cell leukemia","volume":"22","author":"Rutten","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2013.03.003_bib16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1084\/jem.20051787","article-title":"The fate of human Langerhans cells in hematopoietic stem cell transplantation","volume":"203","author":"Collin","year":"2006","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.bbmt.2013.03.003_bib17","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1073\/pnas.0712250105","article-title":"Identification of phosphatidylinositol 4-kinase type II beta as HLA class II\u2013restricted target in graft-versus-leukemia reactivity","volume":"105","author":"Griffioen","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbmt.2013.03.003_bib18","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1182\/blood-2009-03-208017","article-title":"Identification of 4 new HLA-DR\u2013restricted minor histocompatibility antigens as hematopoietic targets in antitumor immunity","volume":"114","author":"Stumpf","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.03.003_bib19","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bbmt.2012.07.020","article-title":"Patient HLA-DP\u2013specific CD4(+) T cells from HLA-DPB1\u2013mismatched donor lymphocyte infusion can induce graft-versus-leukemia reactivity in the presence or absence of graft-versus-host disease","volume":"1","author":"Rutten","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.03.003_bib20","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/sj.bmt.1704142","article-title":"Tissue-restricted T cell alloresponses across HLA barriers: selection and identification of leukemia-restricted CTL in HLA-mismatched stimulator\u2013responder pairs","volume":"32","author":"Fujiwara","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.03.003_bib21","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1182\/blood.V90.3.1083","article-title":"HLA class II\u2013restricted T-cell reactivity to a developmentally regulated antigen shared by leukemic cells and CD34+ early progenitor cells","volume":"90","author":"Mutis","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.03.003_bib22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/(SICI)1521-4141(199801)28:01<193::AID-IMMU193>3.0.CO;2-K","article-title":"Generation of human tumor-reactive cytotoxic T cells against peptides presented by non-self HLA class I molecules","volume":"28","author":"Sadovnikova","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.bbmt.2013.03.003_bib23","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1182\/blood-2009-03-209387","article-title":"Dendritic cells pulsed with RNA encoding allogeneic MHC and antigen induce T cells with superior antitumor activity and higher TCR functional avidity","volume":"114","author":"Wilde","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.03.003_bib24","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.1158\/1078-0432.CCR-11-1066","article-title":"PRAME-specific allo-HLA\u2013restricted T cells with potent antitumor reactivity useful for therapeutic T-cell receptor gene transfer","volume":"17","author":"Amir","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bbmt.2013.03.003_bib25","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1182\/blood.V118.21.3062.3062","article-title":"HLA class II up-regulation during an ongoing viral infection can lead to HLA-DP\u2013directed graft-versus-host disease after HLA-DPB1\u2013mismatched CD4+ donor lymphocyte infusion","volume":"118","author":"Stevanovic","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.03.003_bib26","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nri2200","article-title":"Specificity of T-cell alloreactivity","volume":"7","author":"Felix","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bbmt.2013.03.003_bib27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bbmt.2006.10.025","article-title":"Promiscuity of the AlloHLA-A2\u2013restricted T cell repertoire hampers the generation of minor histocompatibility antigen-specific cytotoxic T cells across HLA barriers","volume":"13","author":"Oosten","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.03.003_bib28","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.4049\/jimmunol.1100852","article-title":"Allogeneic HLA-A*02\u2013restricted WT1-specific T cells from mismatched donors are highly reactive but show off-target promiscuity","volume":"187","author":"Falkenburg","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.bbmt.2013.03.003_bib29","doi-asserted-by":"crossref","first-page":"6806","DOI":"10.1073\/pnas.111162298","article-title":"Dual HLA class I and class II\u2013 restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex","volume":"98","author":"Heemskerk","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbmt.2013.03.003_bib30","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/leu.2011.222","article-title":"Human alloreactive CD4+ T cells as strong mediators of anti-tumor immunity in NOD\/scid mice engrafted with human acute lymphoblastic leukemia","volume":"26","author":"Stevanovic","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2013.03.003_bib31","article-title":"HLA-class II disparity is necessary for effective T cell mediated graft-versus-leukemia effects in NOD\/scid mice engrafted with human acute lymphoblastic leukemia","author":"Stevanovic","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2013.03.003_bib32","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1002\/eji.1830270902","article-title":"Qa-1 interaction and T cell recognition of the Qa-1 determinant modifier peptide","volume":"27","author":"Cotterill","year":"1997","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.bbmt.2013.03.003_bib33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1084\/jem.20091429","article-title":"The nonpolymorphic MHC Qa-1b mediates CD8+ T cell surveillance of antigen-processing defects","volume":"207","author":"Oliveira","year":"2010","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.bbmt.2013.03.003_bib34","doi-asserted-by":"crossref","first-page":"842","DOI":"10.2337\/diab.40.7.842","article-title":"NIT-1, a pancreatic beta-cell line established from a transgenic NOD\/Lt mouse","volume":"40","author":"Hamaguchi","year":"1991","journal-title":"Diabetes"},{"key":"10.1016\/j.bbmt.2013.03.003_bib35","doi-asserted-by":"crossref","first-page":"e37747","DOI":"10.1371\/journal.pone.0037747","article-title":"Mechanism underlying defective interferon gamma-induced IDO expression in non-obese diabetic mouse fibroblasts","volume":"7","author":"Hosseini-Tabatabaei","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbmt.2013.03.003_bib36","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1084\/jem.170.4.1243","article-title":"MHC antigen induction by interferon gamma on cultured mouse pancreatic beta cells and macrophages: genetic analysis of strain differences and discovery of an \u201coccult\u201d class I-like antigen in NOD\/Lt mice","volume":"170","author":"Leiter","year":"1989","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.bbmt.2013.03.003_bib37","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1182\/blood-2009-07-234906","article-title":"Allo-HLA reactivity of virus-specific memory T cells is common","volume":"115","author":"Amir","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.03.003_bib38","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1182\/blood-2002-10-3241","article-title":"A\u00a0new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG2-\/-\u03b3c-\/- double-mutant mice","volume":"102","author":"van Rijn","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.03.003_bib39","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.exphem.2007.06.007","article-title":"Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD\/SCID beta2mnull mice","volume":"35","author":"Nervi","year":"2007","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bbmt.2013.03.003_bib40","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1097\/TP.0b013e3181a5cb07","article-title":"Highly sensitive model for xenogenic GVHD using severe immunodeficient NOG mice","volume":"87","author":"Ito","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2013.03.003_bib41","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1365-2249.2009.03933.x","article-title":"Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host\u2013like disease and the role of host major histocompatibility complex","volume":"157","author":"King","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.bbmt.2013.03.003_bib42","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.bbmt.2012.05.002","article-title":"Histological assessment of the sclerotic graft-versus-host response in the humanized RAG2-\/-\u03b3c-\/- mouse model","volume":"18","author":"Hogenes","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.03.003_bib43","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/338345a0","article-title":"Polymorphism in the alpha 3 domain of HLA-A molecules affects binding to CD8","volume":"338","author":"Salter","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.bbmt.2013.03.003_bib44","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.4049\/jimmunol.155.3.1057","article-title":"Human anti-mouse xenorecognition: provision of noncognate interactions reveals plasticity of T cell repertoire","volume":"155","author":"Batten","year":"1995","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.bbmt.2013.03.003_bib45","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1084\/jem.182.5.1315","article-title":"Human CD8 transgene regulation of HLA recognition by murine T cells","volume":"182","author":"LaFace","year":"1995","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.bbmt.2013.03.003_bib46","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.4049\/jimmunol.156.5.1848","article-title":"Mutations in human CD4 impair the functional interaction with different human and mouse class II isotypes and alleles","volume":"156","author":"Fleury","year":"1996","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.bbmt.2013.03.003_bib47","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/338512a0","article-title":"Cotransfection of ICAM-1 and HLA-DR reconstitutes human antigen-presenting cell function in mouse L cells","volume":"338","author":"Altmann","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.bbmt.2013.03.003_bib48","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/eji.1830230218","article-title":"CD2\/LFA-3 or LFA-1\/ICAM-1 but not CD28\/B7 interactions can augment cytotoxicity by virus-specific CD8+ cytotoxic T lymphocytes","volume":"23","author":"de Waal","year":"1993","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.bbmt.2013.03.003_bib49","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.bbmt.2012.06.017","article-title":"Alloreactive effector T cells require the local formation of a proinflammatory environment to allow crosstalk and high avidity interaction with nonhematopoietic tissues to induce GVHD reactivity","volume":"18","author":"van der Zouwen","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.03.003_bib50","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.exphem.2004.08.006","article-title":"A\u00a0mouse model of lymphocyte infusion-induced bone marrow failure","volume":"32","author":"Bloom","year":"2004","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bbmt.2013.03.003_bib51","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1084\/jem.166.5.1280","article-title":"Tumor necrosis factor\/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs-host disease","volume":"166","author":"Piguet","year":"1987","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.bbmt.2013.03.003_bib52","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.20102538","article-title":"Hemophagocytosis causes a consumptive anemia of inflammation","volume":"208","author":"Zoller","year":"2011","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.bbmt.2013.03.003_bib53","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1172\/JCI37869","article-title":"V\u03b124-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages","volume":"119","author":"Song","year":"2009","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.bbmt.2013.03.003_bib54","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1182\/blood-2011-07-368027","article-title":"Blocking IL-21 signaling ameliorates xenogeneic GVHD induced by human lymphocytes","volume":"119","author":"Hippen","year":"2012","journal-title":"Blood"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879113001079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879113001079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:44:57Z","timestamp":1761057897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879113001079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S1083879113001079"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2013.03.003","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Donor T Cells Administered Over HLA Class II Barriers Mediate Antitumor Immunity without Broad Off-Target Toxicity in a NOD\/Scid Mouse Model of Acute Leukemia","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2013.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}